Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: the Rotterdam preclinical-clinical program

ER (Eric) Manusama, PTGA Nooijen, Timo ten Hagen, AH Veen, MWR de Vries, JHW Wilt, MG IJken, RL (Richard) Marquet, Lex Eggermont

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)232-237
Number of pages6
JournalSeminars in Surgical Oncology
Publication statusPublished - 1998

Research programs

  • EMC MM-03-47-06-A
  • EMC MM-03-47-11

Cite this